3D bioprinting technology developed for cancer immunotherapy

Medical Xpress July 13, 2023
By National Research Council of Science & Technology

A three-dimensional (3D) bioprinting technology capable of eliminating cancer cells using the function of immune cells has been developed for the first time.

Through joint research with the Korea Institute of Machinery and Materials, the Korea Research Institute of Bioscience and Biotechnology, institute under the jurisdiction of the Ministry of Science and ICT, developed a 3D bioprinting technology using natural killer cells (NK cells) as a new method of immunotherapy for treating cancer. The research has been published in Biomaterials Research.

Allowing the 3D-printed hydrogels to encapsulate NK cells helps to prevent the loss of NK cells and enables a majority of those cells to home in on the tumor cells. Pores form in the hydrogel, and NK cells that...

Today's Sponsors

Today's Sponsor